logo
Top stocks to buy: Stock recommendations for the week starting June 2, 2025

Top stocks to buy: Stock recommendations for the week starting June 2, 2025

Time of India4 days ago

Stock market recommendations:
According to Motilal Oswal Financial Services Ltd, the top stock picks for the week (starting June 2, 2025) are Radico Khaitan and JK Cement. Let's take a look:
Stock Name
CMP (Rs)
Target (Rs)
Upside (%)
Radico Khaitan
2547
3000
18%
JK Cement
5465
6060
11%
Radico Khaitan
Radico Khaitan, a legacy player since 1943, is one of the oldest and largest IMFL manufacturers in India with a diverse portfolio across whisky, vodka, gin, rum, and brandy (ranging from INR500 to INR8000), covering a large customer base.
Tired of too many ads? go ad free now
Driven by consistent volume growth (from 20m cases in FY15 to 31m in FY25) & sharp execution, Radico has outperformed peers through premiumisation & is now expanding its premium & luxury portfolio to strengthen trade & consumer pull.
With an ~8% IMFL market share and rising presence in the P&A segment, we estimate a robust 6%/22%/30% in revenue/EBITDA/APAT CAGR during FY25-28E. Overall volume is projected at 9%, driven by a robust 15% CAGR in the P&A portfolio.
JK Cement
JK Cement (JKCE) reported better-than-expected results for 4QFY25, exceeding our estimates primarily due to a strong 15% YoY growth in volumes. Revenue/EBITDA/adj. PAT rose by 15%/37%/69% YoY. Management aims to achieve ~20mt grey cement volume (~12% YoY growth) in FY26. Of the ₹150–200/t cost-saving target, ₹40/t was realized in FY25; FY26 should see ₹25–30/t savings plus a full-year ₹75/t benefit.
JKCE remains one of our preferred picks in the cement sector.
We raise FY26/27E EBITDA by ~4% each on higher volume and better profitability of its UAE plant. We expect its revenue/EBITDA/profits to post a CAGR of 15%/20%/31% over FY25-27E.
Disclaimer: The opinions, analyses and recommendations expressed herein are those of brokerage and do not reflect the views of The Times of India. Always consult with a qualified investment advisor or financial planner before making any investment decisions.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Stocks to buy: Cement sector set for steady growth in FY26; brokerages bullish on THESE four stocks
Stocks to buy: Cement sector set for steady growth in FY26; brokerages bullish on THESE four stocks

Mint

time11 hours ago

  • Mint

Stocks to buy: Cement sector set for steady growth in FY26; brokerages bullish on THESE four stocks

Cement stocks to buy: After a challenging start to FY25, the Indian cement sector rebounded strongly in the March quarter, setting the tone for a more stable and profitable FY26. Supported by firm pricing, cost optimisation, and strong demand recovery, companies across the board delivered better-than-expected results in Q4FY25. Sector-wide EBITDA per metric ton (EBITDA/mt) jumped over ₹ 300 sequentially to ₹ 1,055/mt, marking a clear recovery from the lows of 2QFY25. The industry closed FY25 with an installed capacity of around 655 million tonnes per annum (MTPA), reflecting a 4.8% year-on-year expansion. Major players like UltraTech Cement and JK Cement posted strong volume growth of 16.9% and 14.6% YoY, respectively, driven by both demand revival and contributions from newly acquired assets. During the quarter, UltraTech Cement and Dalmia Bharat commissioned 6.3 mtpa and 2.9 mtpa of new capacity, respectively. Birla Corporation and Dalmia Bharat also announced fresh expansion plans of 6.2 mtpa and 6 mtpa. This capacity addition signals rising confidence in long-term demand trends, supported by increased government infrastructure spending and housing activity. Management commentaries across top players point to a demand growth forecast of 6–7% in FY26. Several brokerages, however, estimate an even higher potential growth of 8–9%, citing tailwinds from urbanisation, rural housing, and commercial real estate. A rebound in residential real estate, along with retail and office space expansion, is also expected to keep cement demand buoyant. Furthermore, pan-India cement prices have risen by approximately 4% in 1QFY26-to-date, led by sharp hikes in southern and eastern markets, which bodes well for regional profitability. While the pricing environment remains healthy—with April 2025 witnessing sharp price hikes in the southern region—early onset of the monsoon could dampen momentum in the first quarter. Brokerages caution that the seasonal weakness could lead to near-term stock consolidation. However, underlying fundamentals remain intact, backed by improving utilization levels and a favorable cost environment, especially for power and fuel. Following Q4 results, brokerages have maintained a positive outlook on the cement sector. Systematix Institutional Equities noted that the industry exited FY25 on a strong note, with improving demand and partial price absorption in key markets like the East and North. Centrum Broking pointed to consolidation-led discipline and improving infrastructure and housing momentum as key growth drivers in FY26, projecting demand growth between 6% and 7.5%. Axis Securities remains positive as long-term demand drivers are intact and expects cement demand to grow at a CAGR of 7%-8% over FY24-27E. It anticipates sector consolidation to benefit large players through economies of scale, supply chain efficiency, and better pricing in the long term. Despite ongoing capacity additions, it believes long-term cement demand will outpace supply. Systematix Institutional Equities has picked UltraTech Cement, Ambuja Cements, and JK Cement as its top picks within its coverage universe, with price targets of ₹ 14,038, ₹ 649, and ₹ 5,863, respectively. Centrum Broking also maintains a bullish stance and recommends UltraTech Cement, Ambuja Cement, and JK Cement, assigning target prices of ₹ 14,038, ₹ 649, and ₹ 5,863, respectively. Axis Securities has listed UltraTech Cement (target price: ₹ 13,510), JK Cement ( ₹ 5,740), and Birla Corporation ( ₹ 1,560) as its top conviction ideas, emphasising the importance of monitoring price trends, fuel costs, and demand revival post-elections. The brokerage retained buy calls on these three counters. JM Financial, too, has reiterated its preference for UltraTech Cement and JK Cement, pointing to expected demand growth, sustainable cost savings, and a gradual improvement in pricing that should support profitability in FY26. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before taking any investment decisions.

Radico Khaitan jumps 11% in seven days
Radico Khaitan jumps 11% in seven days

Business Standard

timea day ago

  • Business Standard

Radico Khaitan jumps 11% in seven days

Radico Khaitan rallied 1.54% to Rs 2,710.95, extending gains for the seventh consecutive trading session. Shares of Radico Khaitan surged 11.07% in seven trading sessions from its recent closing low of Rs 2,440.65 on 26 May 2025. The stock hit a 52-week high of Rs 2,790 today. The counter has soared 89.72% from its 52-week low of Rs 1,428.95 hit on 26 May 2024. On the BSE, 0.46 lakh shares have been traded so far, compared with average daily volumes of 0.11 lakh shares in the past two weeks. The stock had outperformed the market over the past month, rising 7.02% as against the Sensex's 0.24% rise. The scrip had outperformed the market in the past three months, jumping 28.76% as against a 9.85% rise in Sensex. The counter had also outperformed the market in the past year, soaring 72.47% as against Sensex's 12.37% increase. On the technical front, the stock's daily RSI (relative strength index) stood at 69.584. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30. On the daily chart, the stock was trading above its 50-day, 100-day, and 200-day simple moving average (SMA), placed at 2,452.52, 2,318.75, and 2,268.44, respectively. These levels will act as crucial support zones in the near term. Radico Khaitan is among the oldest and one of the largest manufacturers of Indian-made foreign liquor (IMFL) in India. It is one of the few companies in India to have developed its entire brand portfolio organically. The company's standalone net profit jumped 59.76% to Rs 90.71 crore on a 20.9% rise in net sales to Rs 1,304.08 crore in Q4 FY25 over Q4 FY24.

Top stock picks by Motilal Oswal: Large, mid & small cap recommendations
Top stock picks by Motilal Oswal: Large, mid & small cap recommendations

Business Standard

time2 days ago

  • Business Standard

Top stock picks by Motilal Oswal: Large, mid & small cap recommendations

Stock picks by Motilal Oswal Large Cap M&M – Target: ₹3,482 M&M reported a better-than-expected performance in Q4, led by a strong margin beat in FES segment (at 19.4 per cent against 17.3 per cent estimate). Revenue grew 24.5 per cent year-on-year (Y-o-Y), and Earnings before interset, tax, depreciation and amortisation (Ebitda) margin expanded 180 basis points (bp) Y-o-Y to 14.9 per cent, driven by improved ASPs across both the Auto and FES segments. Management remains confident of outperforming the UV industry in FY26, driven by new launches like Thar Roxx, XUV 3XO, and recent EVs. It plans to boost UV capacity to 69,000/85,000 units in FY26/FY27, with a greenfield project for future requirements beyond FY28. We believe M&M is well-placed to outperform across its core business, driven by a healthy recovery in rural areas and new product launches across both UV and tractor segments. We estimate M&M to post compound annual growth rate (CAGR) of 13 per cent/13 per cent/18 per cent in revenue/Ebitda/PAT over FY25–27E. Bharti Airtel – Target: ₹2,110 Bharti's Q4FY25 performance was in-line. India wireless revenue/Ebitda grew 1 per cent/2 per cent quarter-on-quarter (Q-o-Q), offset by fewer days. Consolidated net debt inched up by ₹5,000 crore due to the redemption of $1 billion perpetual bonds. We continue to favour BHARTI's superior execution on premiumisation. Robust free cash flow (FCF) of ₹9,700 crore/₹39,000 in Q4/FY25, along with moderating capex, should lead to significant FCF generation of ₹1 trillion in FY26-27E. We model a 14 per cent/17 per cent CAGR in Bharti's consolidated revenue/Ebitda (FY25-28E) driven by an expected 15 per cent India wireless tariff hike (December 2025), faster home broadband growth, and continued strong double-digit growth in Africa. Mid Cap Punjab National Bank – Target: ₹125 PNB reported a Q4FY25 PAT of ₹4,570 crore (+52 per cent Y-o-Y), in line with estimates, supported by better other income and a lower tax rate. However, NII missed due to a 12 basis points (bp) Q-o-Q decline in net interest margins (NIMs) to 2.81 per cent. Loan growth was healthy Y-o-Y at 15.3 per cent, though modest Q-o-Q; deposits rose 14.4 per cent Y-o-Y. Slippages surged 69 per cent Q-o-Q, mainly from MSME and agri loans, yet gross net performing asset/net non-performing asset (GNPA/ NNPA) ratios improved to 3.95 per cent/0.4 per cent. Management expects stable net interest margins (NIMs) (2.8–3 per cent) and credit growth of 11–12 per cent. With FY27E RoA/RoE at 1.05 per cent/15.5 per cent, improving asset quality, and strong recovery prospects, we reiterate 'Buy'. Radico Khaitan – Target: ₹3,000 Radico Khaitan, a legacy player since 1943, is one of the oldest and largest IMFL manufacturers in India with a diverse portfolio across whisky, vodka, gin, rum, and brandy (ranging from ₹500 to ₹8,000), covering a large customer base. Driven by consistent volume growth (from 20 million cases in FY15 to 31m in FY25) and sharp execution, Radico has outperformed peers through premiumisation and is now expanding its premium and luxury portfolio to strengthen trade and consumer pull. With an 8 per cent IMFL market share and rising presence in the P&A segment, we estimate a robust 6 per cent/22 per cent/30 per cent in revenue/Ebitda/adjusted PAT CAGR during FY25-28E. Overall volume is projected at 9 per cent, driven by a robust 15 per cent CAGR in the P&A portfolio. Small Cap Niva Bupa – Target: ₹100 Niva Bupa reported 18 per cent/25 per cent Y-o-Y growth in Gross Written Premium/Net Earned Premium in Q4, driven by 3 per cent/59 per cent/18 per cent growth in retail health /group health/PA businesses. It secured business from two large corp. accounts, significantly contributing to strong growth in group health. With a Y-o-Y expansion of 50bp/190bp in commission/expense ratios, the combined ratio improved to better-than-expected 92.8 per cent, up 340 bp Y-o-Y. Measures taken to mitigate claim inflation will continue to aid loss ratios, while op. efficiency will lead to improved expense ratio going forward. We believe Niva is well-positioned to harness growth opportunities with a strategic global partner, a growing customer base, and innovative product offerings. The diversified channel mix will ensure improved scalability as the company moves toward geographic expansion. Marico – Target: ₹800 Marico (MRCO) reported Q4FY25 revenue growth of 20 per cent Y-o-Y, with domestic revenue up 23 per cent driven by strong core category performance and new growth drivers. International revenue grew 11 per cent. Ad spends rose 35 per cent, leading to a 260 bp Y-o-Y contraction in Ebitda margin to 16.8 per cent, while Ebitda grew 4 per cent against 7 per cent estimate.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store